[go: up one dir, main page]

WO2008038119A3 - A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system - Google Patents

A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system Download PDF

Info

Publication number
WO2008038119A3
WO2008038119A3 PCT/IB2007/002820 IB2007002820W WO2008038119A3 WO 2008038119 A3 WO2008038119 A3 WO 2008038119A3 IB 2007002820 W IB2007002820 W IB 2007002820W WO 2008038119 A3 WO2008038119 A3 WO 2008038119A3
Authority
WO
WIPO (PCT)
Prior art keywords
carotene
cyclodextrin
complex
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/002820
Other languages
French (fr)
Other versions
WO2008038119A2 (en
Inventor
Rosario Ammirante
Felice Piero Molinari
Monte Federico Mauro Del
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008038119A2 publication Critical patent/WO2008038119A2/en
Publication of WO2008038119A3 publication Critical patent/WO2008038119A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/10—General methods of cooking foods, e.g. by roasting or frying
    • A23L5/15—General methods of cooking foods, e.g. by roasting or frying using wave energy, irradiation, electrical means or magnetic fields, e.g. oven cooking or roasting using radiant dry heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A composition comprising: (a) a complex of coenzyme QlO and at least one cyclodextrin; and (b) at least one carotene; and use thereof for the treatment of various diseases, in particular of neurodegenerative diseases of the central nervous system, particularly of Parkinson's disease (PD).
PCT/IB2007/002820 2006-09-29 2007-09-26 A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system Ceased WO2008038119A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2006A001874 2006-09-29
IT001874A ITMI20061874A1 (en) 2006-09-29 2006-09-29 COMPOSITION FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGICAL STATES OF THE CENTRAL AND PARTICULAR NERVOUS SYSTEM IN PARKINSON'S DISEASE

Publications (2)

Publication Number Publication Date
WO2008038119A2 WO2008038119A2 (en) 2008-04-03
WO2008038119A3 true WO2008038119A3 (en) 2008-11-06

Family

ID=39190249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002820 Ceased WO2008038119A2 (en) 2006-09-29 2007-09-26 A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system

Country Status (2)

Country Link
IT (1) ITMI20061874A1 (en)
WO (1) WO2008038119A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU100797B1 (en) * 2018-05-15 2019-11-15 Univ Luxembourg 2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition
FR3117339B1 (en) 2020-12-16 2025-10-24 Naos Inst Of Life Science Use of bacterioruberins and their glycosylated derivatives to prevent and treat diseases involving dysregulation of protein aggregation, such as neurodegenerative diseases

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011423A2 (en) * 2002-07-29 2004-02-05 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
CN1634075A (en) * 2004-10-28 2005-07-06 昆明翔昊科技有限公司 Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method
US7030102B1 (en) * 2003-05-06 2006-04-18 Bioactives, Llc Highly bioavailable coenzyme Q-10 cyclodextrin complex
EP1681053A1 (en) * 2003-10-31 2006-07-19 Kaneka Corporation Composition containing reduced coenzyme q

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011423A2 (en) * 2002-07-29 2004-02-05 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7030102B1 (en) * 2003-05-06 2006-04-18 Bioactives, Llc Highly bioavailable coenzyme Q-10 cyclodextrin complex
EP1681053A1 (en) * 2003-10-31 2006-07-19 Kaneka Corporation Composition containing reduced coenzyme q
CN1634075A (en) * 2004-10-28 2005-07-06 昆明翔昊科技有限公司 Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method

Also Published As

Publication number Publication date
WO2008038119A2 (en) 2008-04-03
ITMI20061874A1 (en) 2006-12-29

Similar Documents

Publication Publication Date Title
WO2009071690A3 (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
WO2007092329A3 (en) Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
GB2463833A (en) Methods and compositions for the treatment of neurological disorders
ZA200805839B (en) Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
EP1783110A4 (en) Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
WO2007137071A3 (en) Compositions of r(+) and s(-) pramipexole and methods of using the same
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
WO2006095029A3 (en) Di-polymer protein conjugates and processes for their preparation
WO2008060362A3 (en) Methods and compositions for the treatment of skin diseases and disorders
WO2007135426A3 (en) Treatment of neurodegeneratives diseases
WO2010058926A3 (en) Pharmaceutical composition containing ginger extract or shogaol
IL177787A0 (en) 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease
WO2007133983A3 (en) 2-aminobenzimidazoles for treating neurodegenerative diseases
WO2007109288A3 (en) Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use
WO2010041252A3 (en) Use of a cinnamon bark extract for treating amyloid-associated diseases
WO2004082584A3 (en) 5ht2c receptor antagonists in the treatment of schizophrenia
WO2008038119A3 (en) A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system
WO2007022305A3 (en) 2-aminoimidazopyridines for treating neurodegenerative diseases
ZA200900739B (en) N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
CL2007003275A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED 4-IMIDAZOLS; PREPARATION PROCESS; MEDICINE; AND USE FOR THE DEPRESSION TREATMENT, ANXIETY DISORDERS, PSYCHOTIC DISORDERS, SCHIZOPHRENIA, PARKINSON'S DISEASE, MIGRANA, AMONG OTHERS.
USD554735S1 (en) Ultra-violet liquids disinfection device
WO2007015173A3 (en) Inflammation
PL1714647T3 (en) Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
GB0410101D0 (en) Parkinson's disease

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825195

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07825195

Country of ref document: EP

Kind code of ref document: A2